Search for other papers by Rasmus Reinke in
Google Scholar
PubMed
Search for other papers by Stefano Christian Londero in
Google Scholar
PubMed
Search for other papers by Martin Almquist in
Google Scholar
PubMed
Search for other papers by Lars Rejnmark in
Google Scholar
PubMed
Search for other papers by Lars Rolighed in
Google Scholar
PubMed
) or their vascular supply ( 3 ). HypoPT may reduce quality of life ( 4 ) and increases both mortality ( 5 ) and morbidity ( 6 ). Morbidity for patients with hypoPT includes an increased risk of developing chronic kidney disease (CKD) and kidney
Search for other papers by Ulla Schmidt in
Google Scholar
PubMed
Search for other papers by Birte Nygaard in
Google Scholar
PubMed
Search for other papers by Ebbe Winther Jensen in
Google Scholar
PubMed
Search for other papers by Jan Kvetny in
Google Scholar
PubMed
Search for other papers by Anne Jarløv in
Google Scholar
PubMed
Endocrine Unit, Department of Medicine, Endocrine Unit, Faculty of Health Sciences, Department of Medicine O, Herlev University Hospital, Herlev Ringvej, DK-2730 Herlev, Denmark
Search for other papers by Jens Faber in
Google Scholar
PubMed
monotherapy with respect to quality of life (QOL), depression and anxiety rating scales, and the patients' own preference. Our results indicate that peripheral extra-pituitary tissues can register the addition of T 3 to the substitution regimen. The European
BARROW Neurological Institute at Phoenix Children’s Hospital, Phoenix, Arizona, USA
Department of Child Health, University of Arizona College of Medicine – Phoenix, Phoenix, Arizona, USA
Search for other papers by Rachel K Rowe in
Google Scholar
PubMed
Department of Child Health, University of Arizona College of Medicine – Phoenix, Phoenix, Arizona, USA
Department of Biology and Biochemistry, University of Bath, UK
Search for other papers by Benjamin M Rumney in
Google Scholar
PubMed
Department of Child Health, University of Arizona College of Medicine – Phoenix, Phoenix, Arizona, USA
Department of Biology and Biochemistry, University of Bath, UK
Search for other papers by Hazel G May in
Google Scholar
PubMed
Search for other papers by Paska Permana in
Google Scholar
PubMed
Department of Child Health, University of Arizona College of Medicine – Phoenix, Phoenix, Arizona, USA
School of Biological and Health Systems Engineering, Arizona State University, Tempe, Arizona, USA
Search for other papers by P David Adelson in
Google Scholar
PubMed
Search for other papers by S Mitchell Harman in
Google Scholar
PubMed
BARROW Neurological Institute at Phoenix Children’s Hospital, Phoenix, Arizona, USA
Department of Child Health, University of Arizona College of Medicine – Phoenix, Phoenix, Arizona, USA
Search for other papers by Jonathan Lifshitz in
Google Scholar
PubMed
BARROW Neurological Institute at Phoenix Children’s Hospital, Phoenix, Arizona, USA
Department of Child Health, University of Arizona College of Medicine – Phoenix, Phoenix, Arizona, USA
Search for other papers by Theresa C Thomas in
Google Scholar
PubMed
impair quality of life and impede rehabilitation efforts ( 6 , 16 ), and in rare instances, increases risk for mortality ( 17 , 18 , 19 ). Pituitary hormone deficiencies or hypopituitarism, to a limited extent, are reported in TBI survivors, but the
Search for other papers by I M A A van Roessel in
Google Scholar
PubMed
Department of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands
Endo-ERN European Reference Network on Rare endocrine conditions
Search for other papers by J P de Graaf in
Google Scholar
PubMed
Endo-ERN European Reference Network on Rare endocrine conditions
Search for other papers by N R Biermasz in
Google Scholar
PubMed
Division of Endocrinology and Metabolism, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece
Search for other papers by E Charmandari in
Google Scholar
PubMed
Search for other papers by H M van Santen in
Google Scholar
PubMed
detrimental effects on the quality of life. Patients with HD may experience disturbed hunger-satiety and thirst feelings, decreased energy expenditure, behavioral problems, disturbed circadian rhythm, temperature dysregulation and pituitary dysfunction
Search for other papers by Marek Niedziela in
Google Scholar
PubMed
months. Such a visit plan significantly improves the quality of life of patients. Treatment of each patient should be highly individualised, not proposing fixed intervals, because patients have different initial states and therefore require adequate
Search for other papers by Kevin C J Yuen in
Google Scholar
PubMed
Search for other papers by Gudmundur Johannsson in
Google Scholar
PubMed
Search for other papers by Ken K Y Ho in
Google Scholar
PubMed
Search for other papers by Bradley S Miller in
Google Scholar
PubMed
Search for other papers by Ignacio Bergada in
Google Scholar
PubMed
Search for other papers by Alan D Rogol in
Google Scholar
PubMed
period is important for the attainment of normal bone mineral density, body composition, muscle mass and strength, exercise recovery, and maintaining the quality of life ( 42 ). GH stimulation testing during the transition period typically utilizes
Search for other papers by Ja Hye Kim in
Google Scholar
PubMed
Search for other papers by Yunha Choi in
Google Scholar
PubMed
Search for other papers by Soojin Hwang in
Google Scholar
PubMed
Search for other papers by Gu-Hwan Kim in
Google Scholar
PubMed
Search for other papers by Han-Wook Yoo in
Google Scholar
PubMed
Search for other papers by Jin-Ho Choi in
Google Scholar
PubMed
therapy can increase adult height and induce pubertal development, thereby preventing comorbidities and improving patients’ quality of life. Supplementary materials This is linked to the online version of the paper at https://doi.org/10.1530/EC-21
Search for other papers by Aida Javanbakht in
Google Scholar
PubMed
Search for other papers by Massimo D’Apuzzo in
Google Scholar
PubMed
Search for other papers by Behnam Badie in
Google Scholar
PubMed
Search for other papers by Behrouz Salehian in
Google Scholar
PubMed
Tumor metastasis to the pituitary gland is a rare, not well-documented and life-threatening condition associated with a shortened life span. A better understanding of its clinical manifestations could lead to earlier diagnosis, appropriate therapy and potentially improving quality of life. Therefore, we retrospectively studied the charts of patients with pituitary metastases who were treated at the City of Hope National Medical Center (Duarte, CA) from 1984 to 2018. We reviewed and analyzed tumor origin, primary pituitary clinical manifestation, duration between primary tumor diagnosis and pituitary metastasis, type of treatment and patient survival. A total of 11 patients were identified with a mean age of 59.2 years and median survival following the diagnosis of metastasis of 10 months. Breast cancer and lymphoma were the most common primary origins in these cases, and diabetes insipidus and panhypopituitarism were the most common clinical manifestations of their metastasis. We also compared our results with reports in the literature published between 1957 and 2018. A total 289 patients with pituitary metastasis have been reported in the literature. Breast cancer was the most frequent primary origin of the metastasis, and visual symptoms were the most common primary manifestation. The posterior part of the pituitary is more susceptible than the anterior to metastasis. Pituitary metastasis may occur as a consequence of successful primary tumor treatment prolonging the chance of seeding. Future studies are needed to determine the molecular mechanism of metastasis to the pituitary.
Search for other papers by Jian Gong in
Google Scholar
PubMed
Search for other papers by YinJuan Lv in
Google Scholar
PubMed
Search for other papers by YuHao Meng in
Google Scholar
PubMed
Search for other papers by WeiHeng Zhang in
Google Scholar
PubMed
Search for other papers by XiaoCui Jiang in
Google Scholar
PubMed
Search for other papers by Min Xiao in
Google Scholar
PubMed
Prenatal stress can lead to the programming of the neuroendocrine system in male offspring, disrupting the hypothalamic testicular axis and adversely affecting the reproductive health of male offspring. This study aimed to determine the long-term effects of prenatal stress on the KISS1 system in male offspring and the effects on reproductive function in male offspring. Sixteen pregnant females were divided into a prenatal control group (PC,n=8) and a prenatal stress group (PS,n=8). The PS group was modeled with chronic unpredictable mild stress (CUMS) from day 1 of gestation to full-term delivery. Differences between the two groups in various maternal parameters, including glucocorticoid secretion, litter size, and the effects of male offspring birth weight, the KISS1 system, and reproductive function, were determined. Male offspring of PS dams had lower birth weights compared to prenatal controls.KISS1 gene expression is reduced at birth and in adult PS offspring, and its receptor KISS1-R protein is similarly reduced in PS offspring at birth and adulthood. In adulthood, PS male offspring show significantly reduced sex hormone production, altered testicular morphology, reduced maturation of their supporting cells, and decreased expression of connexin 43 (CX43), leading to an altered sperm microenvironment and reduced sperm quality. In conclusion, prenatal stress leads to adverse changes in the KISS1 system in male offspring and decreased reproductive function.
Leiden Institute for Brain and Cognition, Leiden, The Netherlands
Search for other papers by Kimberly Kuiper in
Google Scholar
PubMed
Leiden Institute for Brain and Cognition, Leiden, The Netherlands
Search for other papers by Hanna Swaab in
Google Scholar
PubMed
Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado
Search for other papers by Nicole Tartaglia in
Google Scholar
PubMed
Leiden Institute for Brain and Cognition, Leiden, The Netherlands
Search for other papers by Sophie van Rijn in
Google Scholar
PubMed
The presence of an additional X or Y chromosome (sex chromosome trisomies, SCT) is associated with an increased risk for neurodevelopmental difficulties, including socio-emotional problems, across the life span. Studying emotion regulation in young children with SCT could signal deviations in emotional development that serve as risk markers to guide clinical care. This study explored the presence and variety of emotion regulation strategies in 75 SCT children and 81 population-based controls, aged 1–7 years, during a frustration-inducing event in which physiological (heart rate) and observational data (behavioral responses) were collected. Children with SCT were equally physiologically aroused by the event as compared to controls. However, they showed more emotion regulation difficulties in terms of behavior compared to controls that were not explicable in terms of differences in general intellectual functioning. Specifically, they had a more limited range of behavioral alternatives and tended to rely longer on inefficient strategies with increasing age. The field of practice should be made aware of these early risk findings regarding emotion regulation in SCT, which may potentially lay the foundation for later socio-emotional problems, given the significant impact of emotion regulation on child and adult mental health outcomes. The current results may help to design tailored interventions to reduce the impact of the additional sex chromosome on adaptive functioning, psychopathology, and quality of life.
